| |
 |
|
|
|
|
|
Poster: 271
Visits: 124
Title: The BET bromodomain inhibitor OTX015 (MK-8628) affects the expression of microRNAs involved in the pathogenesis of lymphoma: in vitro and in vivo evidence
Authors: Afua Adjeiwaa Mensah , Luciano Cascione, Eugenio Gaudio, Elena Bernasconi, Chiara Tarantelli, Andrea Rinaldi, Riccardo Bomben, Valter Gattei, Anastasios Stathis, Maria E Riveiro, Emanuele Zucca, Ivo Kwee, Francesco Bertoni
Centre: Lymphoma and Genomics Research Program, IOR Institute of Oncology Research
|
|
You must be registered to reply or comment.
|
|
THE BET BROMODOMAIN INHIBITOR OTX015 (MK-8628) AFFECTS THE EXPRESSION OF MICRORNAS INVOLVED IN THE PATHOGENESIS OF LYMPHOMA: IN VITRO AND IN VIVO EVIDENCE
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 274
Visits: 159
Title: Novel CD37-Targeting Antibody-Drug Conjugate (ADC), IMGN529, Has Synergistic Activity in Combination with Rituximab in Non-Hodgkin Lymphoma (NHL) Models
Authors: Angela Romanelli , JF Ponte, J Deckert, K OCallaghan, JA Coccia, L Lanieri, S Chicklas, R Ruiz-Soto
Centre: ImmunoGen Inc
|
|
|
|
